TY - JOUR
T1 - Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections
T2 - The National Drug Abuse Treatment Clinical Trials Network
AU - Brown, Lawrence S.
AU - Kritz, Steven Allan
AU - Goldsmith, R. Jeffrey
AU - Bini, Edmund J.
AU - Rotrosen, John
AU - Baker, Sherryl
AU - Robinson, Jim
AU - McAuliffe, Patrick
N1 - Funding Information:
Supported by National Institute on Drug Abuse (NIDA)/National Institutes of Health via the New York Node of the National Drug Abuse Treatment Clinical Trials Network (2 U10 DA13046) and the National Drug Abuse Treatment Clinical Trials Network: New York Node: New York University, New York, NY; South Carolina Node: Medical University of South Carolina, Charleston, SC; Florida Node: University of Miami, Coral Gables, FL; Great Lakes Regional Node: Wayne State University, Detroit, MI; Ohio Valley Node: University of Cincinnati, Cincinnati, OH; Rocky Mountain Node: University of CO Health Sciences Center, Denver, CO; New England Node: Yale University, New Haven, CT; Delaware Valley Node: University of Pennsylvania, Philadelphia, PA; Mid-Atlantic Node: Johns Hopkins Univ., Baltimore, MD; Medical College of Virginia, Richmond, VA; Pacific Region Node: University of California at Los Angeles, CA; Oregon Node: Oregon Health Sciences University, Portland, OR; Washington Node: University of Washington, Seattle, WA; Long Island Regional Node: NY State Psychiatric Institute, New York, NY; North Carolina Node: Duke University, Raleigh/Durham, NC; New Mexico Node: University of New Mexico, Albuquerque, NM; Northern New England Node: McLean Hospital, Belmont, MA; California-Arizona Node: University of California at San Francisco, CA.
PY - 2006/6
Y1 - 2006/6
N2 - Illicit drug users sustain the epidemics of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hepatitis C (HCV), and sexually transmitted infections (STIs). Substance abuse treatment programs present a major intervention point in stemming these epidemics. As a part of the "Infections and Substance Abuse" study, established by the National Drug Abuse Treatment Clinical Trials Network, sponsored by National Institute on Drug Abuse, three surveys were developed; for treatment program administrators, for clinicians, and for state and District of Columbia health and substance abuse department administrators, capturing service availability, government mandates, funding, and other key elements related to the three infection groups. Treatment programs varied in corporate structure, source of revenue, patient census, and medical and non-medical staffing; medical services, counseling services, and staff education targeted HIV/AIDS more often than HCV or STIs. The results from this study have the potential to generate hypotheses for further health services research to inform public policy.
AB - Illicit drug users sustain the epidemics of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hepatitis C (HCV), and sexually transmitted infections (STIs). Substance abuse treatment programs present a major intervention point in stemming these epidemics. As a part of the "Infections and Substance Abuse" study, established by the National Drug Abuse Treatment Clinical Trials Network, sponsored by National Institute on Drug Abuse, three surveys were developed; for treatment program administrators, for clinicians, and for state and District of Columbia health and substance abuse department administrators, capturing service availability, government mandates, funding, and other key elements related to the three infection groups. Treatment programs varied in corporate structure, source of revenue, patient census, and medical and non-medical staffing; medical services, counseling services, and staff education targeted HIV/AIDS more often than HCV or STIs. The results from this study have the potential to generate hypotheses for further health services research to inform public policy.
KW - Community treatment program
KW - HIV/AIDS
KW - Hepatitis C virus infection
KW - National Drug Abuse Treatment Clinical Trials Network
KW - Sexually transmitted infections
UR - https://www.scopus.com/pages/publications/33747456336
U2 - 10.1016/j.jsat.2006.02.006
DO - 10.1016/j.jsat.2006.02.006
M3 - Article
C2 - 16716846
AN - SCOPUS:33747456336
SN - 0740-5472
VL - 30
SP - 315
EP - 321
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 4
ER -